OKUR
OnKure Therapeutics, Inc.
NASDAQ: OKUR · HEALTHCARE · BIOTECHNOLOGY
$3.44
-12.02% today
Updated 2026-05-11
Market cap
$157.95M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$2 – $5
Volume
0.3M
OnKure Therapeutics, Inc. (OKUR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $55.22M | $154.02M | $16.00M | $35.73M | $114.91M |
| Cash & equivalents | $53.61M | $124.66M | $11.54M | $29.88M | $110.76M |
| Current assets | $55.02M | $153.73M | $13.62M | $33.77M | $113.00M |
| Total liabilities | $97.34M | $6.81M | $70.42M | $137.58M | $11.08M |
| Current liabilities | $4.58M | $6.20M | $5.54M | $7.29M | $10.53M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $-42.12M | $147.21M | $-54.42M | $-101.84M | $103.83M |
| Retained earnings | $-44.96M | $-84.73M | $-57.07M | $-102.05M | $-154.72M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |